| Todd J Alan, MD | |
|
7219 N Litchfield Rd, Luke Afb, AZ 85309-1529 | |
| (623) 856-2273 | |
| Not Available |
| Full Name | Todd J Alan |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 7219 N Litchfield Rd, Luke Afb, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083620090 | NPI | - | NPPES |
| 47055301100 | Medicaid | NE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 23409 (Nebraska) | Secondary |
| 207Q00000X | Family Medicine | 49059 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Todd J Alan, MD 7219 N Litchfield Rd, Luke Afb, AZ 85309-1529 Ph: (623) 856-2273 | Todd J Alan, MD 7219 N Litchfield Rd, Luke Afb, AZ 85309-1529 Ph: (623) 856-2273 |
News Archive
Cancer therapies including radiation and chemotherapy seek to treat the disease by killing tumor cells. Now a team including researchers at Beth Israel Deaconess Medical Center have shown that the dead and dying cancer cells generated by chemotherapy and targeted cancer therapy paradoxically trigger inflammation that promotes aggressive tumor growth.
In populating the growing brain, neural stem cells must strike a delicate balance between two key processes - proliferation, in which the cells multiply to provide plenty of starting materials - and differentiation, in which those materials evolve into functioning neurons.
In contrast to intramuscular vaccines, only nasal vaccines are able to block the virus in the nose by inducing local immunity in the nasal mucosa, i.e. the portal of entry and multiplication of the virus.
Verisk Health, Inc., a global leader in healthcare data analytics, today announced the release of DxCG Risk Solutions 3.0, a suite of risk adjustment and predictive modeling products that enable organizations to analyze, predict, manage, and minimize healthcare risk and costs associated with commercial, Medicare, and Medicaid populations.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced the United States Food and Drug Administration (FDA) granted orphan designation for ACE-031 for the treatment of Duchenne Muscular Dystrophy (DMD), a fatal neuromuscular disease in which patients experience a progressive loss of muscle mass and strength. ACE-031 is an investigational protein therapeutic being developed to increase muscle mass and strength.
› Verified 2 days ago
Dr. Manuel A Nunez, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 7219 N Litchfield Rd, Luke Afb, AZ 85309 Phone: 623-856-6121 | |
Dr. Troy M Schwartz, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 56 Medical Group, 7219 N Litchfield Rd, Luke Afb, AZ 85309 Phone: 623-856-4188 | |
Grant C Phillips, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7219 N Litchfield Rd, Luke Afb, AZ 85309 Phone: 623-856-3279 Fax: 623-856-2210 | |
Dr. Robert Wilson, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7219 N Litchfield Rd, Luke Air Force Base - Family Medicine Dept, Luke Afb, AZ 85309 Phone: 623-856-9007 | |
Dr. Joel A. Morton, D.O Family Medicine Medicare: Medicare Enrolled Practice Location: 7219 N Litchfield Rd, Luke Afb, AZ 85309 Phone: 623-856-9321 Fax: 623-856-2777 | |
Dr. Robert J. Downey, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 7219 N Litchfield Rd, Luke Afb, AZ 85309 Phone: 623-856-4161 Fax: 623-856-3107 |